Amplion, a leading precision medicine intelligence company, has released Dx:Revenue, a groundbreaking software solution that enables test providers to identify ideal pharmaceutical partnership opportunities at the right time to advance precision medicine collaboration. Dx: Revenue is an extension of Amplion's core business intelligence platform that leverages proprietary machine learning to deliver tailored insights into pharma and test developer activities. The platform draws from more than 34 million evidence sources such as clinical trials, scientific publications, conference abstracts, FDA cleared and approved tests, lab developed tests, diagnostic and drug pipelines and more in real time, producing prioritized and timely partnering opportunities that are a precise match between a test provider's capabilities and pharma's specific needs. "Precision medicine has a problem," says Chris Capdevila, CEO, Amplion. "There is an insurmountable volume of information with the potential to drive the realization of precision medicine for patients, but accessing that information strategically, effectively and quickly to make the best pharma partnering decisions is beyond human scale. Our company was founded to address this issue by providing critical evidence-based intelligence that supports the strategic decisions pharmaceutical and test developers need to make to be successful."
We thank Twist Bioscience for synthesizing and cloning ChR sequences, D. Wagenaar (California Institute of Technology) and the Caltech Neurotechnology Center for building the mouse treadmill, J. Brake (California Institute of Technology) for performing spectrometer measurements, J. Bedbrook for critical reading of the manuscript and the Gradinaru and Arnold laboratories for helpful discussions. This work was funded by the Institute for Collaborative Biotechnologies grant no. W911NF-09-0001 from the US Army Research Office (F.H.A) and the National Institutes of Health (NIH) (V.G.): NIH BRAIN grant no. RF1MH117069, NIH Director's Pioneer Award grant no. DP1NS111369, NIH Director's New Innovator Award grant no.
Every summer there is a mass exodus from New York City towards the white beach at Jones Beach State Park. Here, looking out over the Atlantic Ocean, you can sunbathe, catch a concert or play a game of mini-golf. And get away from the bustle of the city. But you have to get there first. And there's something odd about the route you take. The flyovers over the Southern State Parkway that leads to Jones Beach are low.
By 2030 the total gross domestic product of the world will be 14% higher because of one thing: more use of artificial intelligence or AI. That's the conclusion of PwC, a professional services firm based in London. If such forecasts are right these sophisticated computer programs will be doing tasks such as driving vehicles, planning and waging wars, and advising humans on how to handle both their health and wealth. One observer writing in the Journal of the American Medical Association has declared that the "hype and fear" surrounding AI "may be greater than that which accompanied the discovery of the structure of DNA or the whole genome." Yet despite the possibility of colossal impacts from AI, the U.S. government has been doing little to study its ethical implications.
The Trump administration, as part of its strategy on artificial intelligence, has spent a considerable amount of time identifying jobs that become obsolete with the rise of automation. As part of that effort, agencies have also looked at predicting what new career paths automation might create in the years ahead. But now some officials say fear over automation-related job security might have gone too far. Federal Chief Information Officer Suzette Kent, who has overseen some of the administration's reskilling pilots, like the Federal Cyber Reskilling Academy, said some of these anxieties about automation aren't new. "This is not a story that we haven't heard before in our nation: Something comes along that radically changes the way that we work, the way that we live, and creating fear about that is not the best path forward," Kent said during a panel hosted by the Bipartisan Policy Center on Wednesday.
Artificial intelligence salaries benefit from the perfect recipe for a sweet paycheck: a hot field and high demand for scarce talent. It's the ever-reliable law of supply and demand, and right now, anything artificial intelligence-related is in very high demand. According to Indeed.com, the average IT salary -- the keyword is "artificial intelligence engineer" -- in the San Francisco area ranges from approximately $134,135 per year for "software engineer" to $169,930 per year for "machine learning engineer." However, it can go much higher if you have the credentials firms need. One tenured professor was offered triple his $180,000 salary to join Google, which he declined for a different teaching position.
WASHINGTON – U.S. astronauts Christina Koch and Jessica Meir on Friday became the first female pairing to carry out a spacewalk -- a historic milestone as NASA prepares to send the first woman to the moon. "It symbolizes exploration by all that dare to dream and work hard to achieve that dream," Meir said after the seven-hour and 17-minute spacewalk to replace a power controller on the International Space Station. The mission was originally planned for earlier this year but had to be aborted due to a lack of properly fitting spacesuits, leading to allegations of sexism. Koch and Meir began the walk with standard safety checks on their suits and tethers, before making their way to the repair site on the station's port side as the sunlit Earth came into view. In a call to reporters just a few minutes before, NASA Administrator Jim Bridenstine emphasized the symbolic significance of the day.
After years of development, Alphabet's drone delivery service Wing is officially open for business. The company announced the beginning of service for residents of Christiansburg, Virginia, who will be able to order over-the-counter medication, snacks, and other small items and have them airlifted straight to their homes by a drone. Initially, Wing will deliver goods on behalf of three partner companies with FedEx, Walgreens, and Super Magnolia, a local Virginia grocery store chain. After years of preparation, Alphabet's drone delivery service Wing has officially begun operations in Christiansburg, Virginia The company made the announcement via a blog post on Medium and included a video showing how the delivery service will work. The FAA approved Alphabet's drone delivery program in March, and the company announced it's plans for'store to door' of more than 100 products in Virginia last September.
NSF's AI Research Institutes program will support longer-term research than typical grants. The National Science Foundation today announced the creation of a new program that will significantly advance research in AI and accelerate the development of transformational, AI-powered innovation by allowing researchers to focus on larger-scale, longer-term research. The National Artificial Intelligence Research Institutes program anticipates approximately $120 million in grants next year to fund planning grants and up to six research institutes in order to advance AI research and create national nexus points for universities, federal agencies, industries and nonprofits. "Advances in AI are progressing rapidly and demonstrating the potential to transform our lives," said NSF Director France Córdova. "This landmark investment will further AI research and workforce development, allowing us to accelerate the development of transformational technologies and catalyze markets of the future."
Artificial intelligence and machine learning have been utilized for years in the field of healthcare and continue to grow tremendously each year with its ability to advance medicine and discoveries in the industry. The term "precision medicine", sometimes referred to as "personalized medicine," is a relatively new term in the healthcare field but the idea has been around for many years in the industry. According to the U.S. National Library of Medicine, precision medicine is "an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person." Precision medicine helps physicians determine more personalized treatments for patients considering individualized approaches instead of a blanketed approach for all patients. They do this by looking at a patient's genetic history, location, environmental factors, lifestyle and habits to determine a plan of action for treatment.